| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/29/2010 | EP2231673A1 Method for the preparation of morphine compounds |
| 09/29/2010 | EP2231660A1 Imidazo [1,2-a] pyridine compounds |
| 09/29/2010 | EP2231659A1 Translocator protein ligands |
| 09/29/2010 | EP2231611A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 09/29/2010 | EP2231610A1 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 09/29/2010 | EP2231609A1 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 09/29/2010 | EP2231608A1 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 09/29/2010 | EP2231173A1 Nutraceutical composition and methods of use |
| 09/29/2010 | EP2231158A2 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 09/29/2010 | EP2231156A1 Methods for increasing white blood cells |
| 09/29/2010 | EP2231153A2 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 09/29/2010 | EP2231140A1 Sigma ligands and ikk / nf - kb inhibitors for medical treatment |
| 09/29/2010 | EP2231138A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 09/29/2010 | EP2231136A1 Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 09/29/2010 | EP2231129A1 Therapeutic regimens for the treatment of immunoinflammatory disorders |
| 09/29/2010 | EP1960398B1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 09/29/2010 | EP1768979B1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | EP1421074B1 Novel compounds |
| 09/29/2010 | EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 09/29/2010 | CN1970045B Externally applied Chinese medicine for treating cervical and lumbar spondylosis |
| 09/29/2010 | CN1893963B Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 09/29/2010 | CN1872037B Drop pills of paeonol, and preparation method |
| 09/29/2010 | CN1816549B Inhibitors of phosphatidylinositol 3-kinase |
| 09/29/2010 | CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
| 09/29/2010 | CN101848909A Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases |
| 09/29/2010 | CN101848717A Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 09/29/2010 | CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/29/2010 | CN101845099A Long-acting analgesic peptide and application thereof |
| 09/29/2010 | CN101844997A Method for synthesizing benorilate by catalytically esterifying 4-dimethylamino pyridine |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843886A Medicine containing saussurea and for curing rheumatic bone disease and preparation method thereof |
| 09/29/2010 | CN101843885A Medicament for treating distention and pain in chest and hypochondrium |
| 09/29/2010 | CN101843875A Chinese medicinal preparation for treating acute soft tissue inflammation |
| 09/29/2010 | CN101843810A Medicinal liquor for treating bi syndromes and preparation method thereof |
| 09/29/2010 | CN101843801A Bone permeable blood-activating and pain-relieving tincture |
| 09/29/2010 | CN101843795A Yang-warming and dampness-removing Chinese medicinal composition formula and preparation method thereof |
| 09/29/2010 | CN101843747A Chinese medicament for treating rheumatoid arthritis |
| 09/29/2010 | CN101843667A Shuanghuanglian medicinal composition and preparation method thereof |
| 09/29/2010 | CN101843666A Analgesic medicine compound containing hydrochloric acid isocorydine hydis |
| 09/29/2010 | CN101843664A Sake drug for treating rheumatism |
| 09/29/2010 | CN101843663A Preparation method of extract package of volatile oil heavier than water |
| 09/29/2010 | CN101843638A Method for extracting horny substance liquid by using animal horns or hooves and equipment thereof |
| 09/29/2010 | CN101843632A Application of miR-145 in preparing medicament for treating inflammation |
| 09/29/2010 | CN101843625A Compound ofloxacin injection for livestock and preparation method thereof |
| 09/29/2010 | CN101843576A Spot eliminating mask |
| 09/29/2010 | CN101843541A Patch instrument for accelerating wound paining curing |
| 09/29/2010 | CN101524190B Disease preventing and curing medicinal mouth-muffle and medicinal composition |
| 09/29/2010 | CN101337931B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/29/2010 | CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease |
| 09/29/2010 | CN101313891B Palmatine injection and preparation method thereof |
| 09/29/2010 | CN101269058B Spraying agent containing diclofenac acid and uses thereof |
| 09/29/2010 | CN101254262B Wounds antiphogistic and antalgic plaster |
| 09/29/2010 | CN101234168B Compound angelica sinensis preparations and preparation and application |
| 09/29/2010 | CN101218983B Chinese medicinal herb cold tea |
| 09/29/2010 | CN101138544B Diclofenac or the salt partial film forming gel composition and uses thereof |
| 09/29/2010 | CN101108190B Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease |
| 09/29/2010 | CN101084989B Method for preparing general flavone and total alkaloid of sophora flavescens simultaneously |
| 09/29/2010 | CN101007072B Quality-control method of a traditional Chinese medicine 'Xuebijing' injection |
| 09/29/2010 | CN101006087B Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 09/28/2010 | USRE41783 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/28/2010 | US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 09/28/2010 | US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases |
| 09/28/2010 | US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 09/28/2010 | US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 09/28/2010 | US7803795 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis |
| 09/28/2010 | US7803791 biological conjugate drug comprising enzyme inhibitor antibiotics and protein, for the treatment and/or prophylaxis of bacterial inflammatory processes, solid tumor; norfloxacin with albumin; antiinflammatory agents, antitumor agents |
| 09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 09/28/2010 | US7803757 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/28/2010 | US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 09/28/2010 | US7803373 Chemokine panec-1 antibodies |
| 09/28/2010 | CA2562992C Probucol analogues, and use thereof as anti-inflammatory inhibitors of vcam-1 |
| 09/28/2010 | CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 09/28/2010 | CA2480065C Injectable veterinary composition for small animals |
| 09/28/2010 | CA2448038C Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 09/28/2010 | CA2395772C Sulfonamide-containing heterocyclic compounds |
| 09/28/2010 | CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity |
| 09/28/2010 | CA2383524C Thiazolyl alkynyl compounds and methods of use thereof |
| 09/28/2010 | CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/23/2010 | WO2010107807A2 Compounds for treating inflammation and pain |
| 09/23/2010 | WO2010107108A1 Rheumatoid arthritis treatment agent |
| 09/23/2010 | WO2010106988A1 Amide derivative |
| 09/23/2010 | WO2010106812A1 Pharmaceutical formulation containing improved antibody molecules |
| 09/23/2010 | WO2010106016A1 Pyrimidine derivatives used as itk inhibitors |
| 09/23/2010 | WO2010105446A1 A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof |
| 09/23/2010 | WO2010079514A4 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate |
| 09/23/2010 | WO2010074453A3 Composition for treating gout, containing angelica gigas extract having a xanthine oxidase-inhibiting effect and an inflammation-inducing enzyme-inhibiting effect |
| 09/23/2010 | WO2010073011A3 Heterocyclic compounds and their use as ampk activators |
| 09/23/2010 | WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 09/23/2010 | US20100240893 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 09/23/2010 | US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells |
| 09/23/2010 | US20100240758 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 09/23/2010 | US20100240756 Compounds for treating inflammation and pain |
| 09/23/2010 | US20100240751 Methods |
| 09/23/2010 | US20100240749 Anesthetic spray composition |